Algemeen nieuws

Algemeen nieuws

Lieve Tytgat appointed professor of biomarkers

Lieve Tygat, professor of biomarkers

How can we better monitor the disease progression of children with solid tumors? That is the question Lieve Tytgat focuses on. As of 1 January 2024, she has been appointed professor of biomarkers in pediatric solid tumors at UMC Utrecht. She primarily focuses on the further development of blood and urine tests to better detect and monitor childhood cancer. "If necessary and possible, we can then adjust the treatment more quickly."

Read more

UMC Utrecht and Philips speed up development of image-guided treatments

UMC Utrecht and Philips are bringing together healthcare professionals, researchers and technicians in a 'fieldlab'. Here, they will develop new innovative technology and software to benefit healthcare. The goal is to devise less burdensome and more efficient treatments for patients, while at the same time realizing a more sustainable healthcare system.

Read more

New study speeds up radiation therapy

Nurses preparing a patient for treatment in the MR-Linac

A targeted radiation therapy that lasts only 15 minutes, instead of 45 minutes. Plus: an even more precise, real-time treatment of the tumor. These are the two goals of a new study by UMC Utrecht to further innovate the MR-Linac. NWO has granted 1.7 million euros to this research project.

Read more

Four new cancer research projects at UMC Utrecht receive Hanarth grants

How can artificial intelligence be used to improve treatment in cancer patients? Researchers from UMC Utrecht are working on this question. Four research projects at UMC Utrecht received funding for this from the Hanarth Fonds.

Read more

Paediatricians happy with Health Council advice on vaccination against RS virus

UMC Utrecht and The Wilhelmina Children's Hospital think it is good news for babies and their parents that the Health Council recommends including a vaccination against the RS virus for infants in the National Vaccination Programme. This vaccination protects infants against the RS virus during their first vulnerable months, and it also provides broad societal benefits. The number of hospital admissions due to the RS virus can fall by 80 per cent, scientific research shows.

Read more

Research TNO and UMC Utrecht for more reliable allergen information on food labels

As of January 1, 2024, the Netherlands has implemented a new allergens policy. Exposure standards have been set and regulations on warning about the potential (unintended) presence of substances that can cause allergy (allergens) on food labels have been tightened. This will make the presence and absence of a warning for allergic consumers significantly more reliable. By January 1, 2026, all producers of pre-packaged foods must comply with the new regulations. The new policy is based on recommendations from the WHO (World Health Organization) and FAO (Food and Agriculture Organization of the United Nations). Research conducted by TNO and UMC Utrecht on the sensitivity of individuals with food allergies and their eating habits formed the basis for these scientific recommendations.

Read more

'I learned to look at patients specifically'

Portrait picture of Hans Derks, professor of paediatric soft tissue and bone sarcomas at UMC Utrecht.

Hans Merks, professor of paediatric soft tissue and bone sarcomas at UMC Utrecht, delivered his oration on Friday 2 February, titled 'Look and marvel'. A speech about sarcoma research, deeper layers that you only start to see when you realise it and the search for effective treatments for children.

Read more

Precision medicine to treat effectively

Marcel Kool

Marcel Kool, professor of Childhood brain tumors at UMC Utrecht, delivered his oration on Wednesday 24 January, titled "Pediatric Brain Tumors - WHO cares!?" on the different types of brain tumors in children, developments in precision medicine and the search for effective treatments.

Read more

New, innovative breast cancer research

breast cancer symbol

How can AI help pathologists find metastases in breast cancer faster (and in an less expensive way)? And why are breast cancer tumors more likely to be more aggressive in pregnant women? Two new innovative studies from UMC Utrecht evolve around these questions. Researchers present the results today at the leading San Antonio Breast Cancer Symposium.

Read more

Nominate your colleague for the Best Support Award

With the Best Support Award we put colleagues in the spotlight who do an enormous amount of work behind the scenes. Have you had a lot of help from a colleague and would you like to thank them for that? Then nominate your colleague before February 16 for the Best Support Award. The presentation will be during the Diversity & Inclusion Award ceremony at Utrecht University on March 26, 2024.

Read more

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not